Literature DB >> 23307875

Vascular function during prolonged progression and regression of atherosclerosis in mice.

Jordan D Miller1, Yi Chu, Lauren E Castaneda, Kristine M Serrano, Robert M Brooks, Donald D Heistad.   

Abstract

OBJECTIVE: Endothelial dysfunction is associated with atherosclerosis in mice, but it is difficult to reduce cholesterol levels enough to study regression of atherosclerosis in genetically modified mice. The goal of this study was to examine vascular structure and function before and after reducing elevated plasma lipid levels with a genetic switch in Reversa mice, and identify novel mechanisms contributing to structural and functional improvements in the vasculature after reduction of blood lipids. METHODS AND
RESULTS: After 6 months of hypercholesterolemia, endothelial function (maximum relaxation to acetylcholine) in aorta was impaired and responses to nitric oxide were unaffected. Further impairment in endothelial function was observed after 12 months of hypercholesterolemia and was associated with reductions in sensitivity to nitric oxide. Expression of dihydrofolate reductase was reduced at 6 and 12 months, and addition of the tetrahydrobiopterin precursor sepiapterin significantly improved endothelial function. Reducing cholesterol levels at 6 months normalized dihydrofolate reductase expression and prevented further impairment in endothelial function. Similar functional changes were observed after 12 months of hypercholesterolemia followed by 2 months of lipid lowering.
CONCLUSIONS: Our data suggest that endothelial dysfunction after prolonged hypercholesterolemia is the result of both impairment of sensitivity to nitric oxide and reduced nitric oxide synthase cofactor bioavailability. Both of these changes can be prevented by normalizing blood lipids during moderately severe or advanced atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23307875      PMCID: PMC3960951          DOI: 10.1161/ATVBAHA.112.252700

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  36 in total

1.  Decreased sensitivity to nitric oxide in the aorta of severely hypercholesterolemic apolipoprotein E-deficient mice.

Authors:  M Yaghoubi; J Oliver-Krasinski; A J Cayatte; R A Cohen
Journal:  J Cardiovasc Pharmacol       Date:  2000-12       Impact factor: 3.105

Review 2.  Vascular endothelium, hemodynamics, and the pathobiology of atherosclerosis.

Authors:  Michael A Gimbrone; Guillermo García-Cardeña
Journal:  Cardiovasc Pathol       Date:  2012-07-18       Impact factor: 2.185

3.  p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice.

Authors:  P A Barry-Lane; C Patterson; M van der Merwe; Z Hu; S M Holland; E T Yeh; M S Runge
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

4.  Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  K Kauser; V da Cunha; R Fitch; C Mallari; G M Rubanyi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-05       Impact factor: 4.733

5.  The development of calcium deposits in atherosclerotic lesions and their persistence after lipid regression.

Authors:  H C Stary
Journal:  Am J Cardiol       Date:  2001-07-19       Impact factor: 2.778

Review 6.  Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis.

Authors:  Gabriella Leonarduzzi; Paola Gamba; Simona Gargiulo; Fiorella Biasi; Giuseppe Poli
Journal:  Free Radic Biol Med       Date:  2011-10-02       Impact factor: 7.376

7.  Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice.

Authors:  P J Kuhlencordt; R Gyurko; F Han; M Scherrer-Crosbie; T H Aretz; R Hajjar; M H Picard; P L Huang
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

8.  Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice.

Authors:  R Scalia; M E Gooszen; S P Jones; M Hoffmeyer; D M Rimmer; S D Trocha; P L Huang; M B Smith; A M Lefer; D J Lefer
Journal:  Circulation       Date:  2001-05-29       Impact factor: 29.690

Review 9.  Natural history of calcium deposits in atherosclerosis progression and regression.

Authors:  H C Stary
Journal:  Z Kardiol       Date:  2000

10.  Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice.

Authors:  J Chen; P J Kuhlencordt; J Astern; R Gyurko; P L Huang
Journal:  Circulation       Date:  2001-11-13       Impact factor: 29.690

View more
  7 in total

1.  Longitudinal analysis of short-term high-fat diet on endothelial senescence in baboons.

Authors:  Qiang Shi; Peter J Hornsby; Qinghe Meng; Jane F Vandeberg; John L Vandeberg
Journal:  Am J Cardiovasc Dis       Date:  2013-08-16

Review 2.  Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension.

Authors:  Qiang Li; Ji-Youn Youn; Hua Cai
Journal:  J Hypertens       Date:  2015-06       Impact factor: 4.844

Review 3.  Atherosclerosis.

Authors:  Hong Lu; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03       Impact factor: 8.311

4.  Arrested Hematopoiesis and Vascular Relaxation Defects in Mice with a Mutation in Dhfr.

Authors:  Julie A I Thoms; Kathy Knezevic; Jia Jenny Liu; Elias N Glaros; Thuan Thai; Qiao Qiao; Heather Campbell; Deborah Packham; Yizhou Huang; Peter Papathanasiou; Robert Tunningley; Belinda Whittle; Amanda W S Yeung; Vashe Chandrakanthan; Luke Hesson; Vivien Chen; Jason W H Wong; Louise E Purton; Robyn L Ward; Shane R Thomas; John E Pimanda
Journal:  Mol Cell Biol       Date:  2016-03-31       Impact factor: 4.272

Review 5.  Tetrahydrobiopterin in cardiovascular health and disease.

Authors:  Jennifer K Bendall; Gillian Douglas; Eileen McNeill; Keith M Channon; Mark J Crabtree
Journal:  Antioxid Redox Signal       Date:  2014-03-14       Impact factor: 8.401

Review 6.  Does Glucagon-like Peptide-1 Ameliorate Oxidative Stress in Diabetes? Evidence Based on Experimental and Clinical Studies.

Authors:  Karen Ekkelund Petersen; Günaj Rakipovski; Kirsten Raun; Jens Lykkesfeldt
Journal:  Curr Diabetes Rev       Date:  2016

Review 7.  Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life.

Authors:  Jennifer G Robinson; Kevin Jon Williams; Samuel Gidding; Jan Borén; Ira Tabas; Edward A Fisher; Chris Packard; Michael Pencina; Zahi A Fayad; Venkatesh Mani; Kerry Anne Rye; Børge G Nordestgaard; Anne Tybjærg-Hansen; Pamela S Douglas; Stephen J Nicholls; Neha Pagidipati; Allan Sniderman
Journal:  J Am Heart Assoc       Date:  2018-10-16       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.